ArticlePharmaceutics2023

Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database.

Fabrizio Calapai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.